Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$613M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$479M |
| 3 |
Willis Towers Watson
WTW
|
+$456M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$370M |
| 5 |
AGN
Allergan plc
AGN
|
+$362M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.05B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$379M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$330M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$327M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$285M |
Sector Composition
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.49% |
| 3 | Financials | 10.81% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
1701
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.09M | ﹤0.01% |
22,911
-3,012
| -12% | -$143K |
|
1702
Benchmark Electronics
BHE
$1.41B
| $1.09M | ﹤0.01% |
54,301
-14,482
| -21% | -$290K |
|
1703
iShares Morningstar Mid-Cap ETF
IMCB
$1.19B
| $1.09M | ﹤0.01% |
28,344
-384
| -1% | -$14.7K |
|
1704
Atlantic Union Bankshares
AUB
$5.05B
| $1.08M | ﹤0.01% |
49,427
+22,833
| +86% | +$500K |
|
1705
Galicia Financial Group
GGAL
$4.81B
| $1.08M | ﹤0.01% |
153,562
+34,044
| +28% | +$240K |
|
|
SRG
1706
Seritage Growth Properties
SRG
$237M
| $1.08M | ﹤0.01% |
118,851
-3,948
| -3% | -$36K |
|
1707
BlackRock Municipal 2030 Target Term Trust
BTT
$1.48B
| $1.08M | ﹤0.01% |
47,672
+3,046
| +7% | +$69.1K |
|
1708
Veracyte
VCYT
$2.43B
| $1.08M | ﹤0.01% |
44,406
-10,357
| -19% | -$252K |
|
1709
Zurn Elkay Water Solutions
ZWS
$7.82B
| $1.08M | ﹤0.01% |
98,872
+16,662
| +20% | +$182K |
|
|
FBC
1710
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.08M | ﹤0.01% |
54,377
+8,810
| +19% | +$175K |
|
1711
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.8B
| $1.08M | ﹤0.01% |
20,327
+7,373
| +57% | +$390K |
|
|
ELME
1712
Elme Communities
ELME
$1.51B
| $1.07M | ﹤0.01% |
45,009
-32,974
| -42% | -$787K |
|
|
TGI
1713
DELISTED
Triumph Group
TGI
| $1.07M | ﹤0.01% |
158,717
-50,510
| -24% | -$341K |
|
1714
Addus HomeCare
ADUS
$2.03B
| $1.07M | ﹤0.01% |
15,845
-989
| -6% | -$66.8K |
|
1715
Pinnacle Financial Partners
PNFP
$7.55B
| $1.07M | ﹤0.01% |
28,517
-708
| -2% | -$26.6K |
|
1716
iShares Morningstar US Equity ETF
ILCB
$1.13B
| $1.07M | ﹤0.01% |
29,176
-10,184
| -26% | -$373K |
|
1717
Synovus
SNV
$7.18B
| $1.07M | ﹤0.01% |
60,897
-146,903
| -71% | -$2.58M |
|
1718
Darling Ingredients
DAR
$4.97B
| $1.07M | ﹤0.01% |
55,693
-206,665
| -79% | -$3.96M |
|
1719
Woodward
WWD
$14.3B
| $1.07M | ﹤0.01% |
17,953
+7,002
| +64% | +$416K |
|
1720
iShares MSCI Canada ETF
EWC
$3.26B
| $1.07M | ﹤0.01% |
48,793
+29,723
| +156% | +$649K |
|
1721
Cleveland-Cliffs
CLF
$5.78B
| $1.06M | ﹤0.01% |
269,294
+25,195
| +10% | +$99.5K |
|
1722
Xtrackers Municipal Infrastructure Revenue Bond ETF
RVNU
$133M
| $1.06M | ﹤0.01% |
38,700
+700
| +2% | +$19.2K |
|
1723
Pricesmart
PSMT
$3.52B
| $1.06M | ﹤0.01% |
20,223
+6,370
| +46% | +$335K |
|
1724
Insmed
INSM
$30.8B
| $1.06M | ﹤0.01% |
66,285
-60,322
| -48% | -$966K |
|
1725
Pacira BioSciences
PCRX
$1.22B
| $1.06M | ﹤0.01% |
31,563
-8,680
| -22% | -$291K |
|